Journal of Global Pharma Technology
Volume 10 Issue 10: 2018

Auto-antibodies Profile in Children Infected with Visceral Leishmaniasis

Entsar Jabbar Saheb (Unknown)



Article Info

Publish Date
29 Dec 2018

Abstract

Visceral leishmaniasis (VL) is a parasitic infection caused by an intracellular growth of Leishmania spp. in macrophage cells. The autoimmune disorder is a condition takes place when the immune system produces antibodies which incorrectly attacked its own body tissues. VL has been involved as an effect or on the autoimmune aspect. This study was conducted to identify the auto antibodies profile in patients infected with VL.  The presences of auto antibodies in 21 Iraqi children infected with VL were tested for laboratory autoimmune aspect. The highest percentage of seropositive in Leishmania patients was observed for anti-ds DNA, anti-Mi-2, anti-Ku and anti-PCNA antibodies (90.5%, 90.5% , 90.5% and 61.9%) respectively, while the lowest percentage was recorded for anti-Histone, anti-R0(RPP), anti-SS-A/Ro 52, anti-Scl 70, anti-Jo-1 antibodies (4.8%) while the auto antibodies (anti-SmD1, anti-SS-A/Ro-60, anti-SS-B/La, anti-CENP, anti-U1snRNP, anti-AMA M2, anti-PM/Scl) showed different profiles in Leishmania patients. These results provide evidence that VL can have an effective role in the production of the auto antibodies.Keywords: Children, Leishmania spp, Visceral leishmaniasis, Auto antibodies.

Copyrights © 2018






Journal Info

Abbrev

jgpt

Publisher

Subject

Medicine & Pharmacology

Description

ournal of Global Pharma Technology is a monthly, open access, Peer review journal of Pharmacy published by JGPT Journal publishes peer-reviewed original research papers, case reports and systematic reviews. The journal allows free access to its contents, which is likely to attract more readers and ...